Criteria for comparisons and recommendations for a next generation of Chimeric Antigen Receptor (CAR) T cells as HIV-1 treatment
Combination antiretroviral therapy (cART) for Human Immunodeficiency Virus Type 1 (HIV-1) treatment is limited in its ability to target HIV reservoirs that cause a viral rebound in patients. Chimeric antigen receptor (CAR) T cell therapy is a developing treatment to address this issue. Several gener...
Saved in:
Main Author: | Sabado, Anne Kimberly Bueno |
---|---|
Format: | text |
Language: | English |
Published: |
Animo Repository
2022
|
Subjects: | |
Online Access: | https://animorepository.dlsu.edu.ph/etdb_bio/19 https://animorepository.dlsu.edu.ph/cgi/viewcontent.cgi?article=1021&context=etdb_bio |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | De La Salle University |
Language: | English |
Similar Items
-
IMPROVING THE EFFICACY OF CHIMERIC ANTIGEN RECEPTOR-T CELLS FOR CANCER THERAPY
by: NATASHA VINANICA
Published: (2020) -
CD28 CO-STIMULATION AND CANCER IMMUNOTHERAPY WITH CHIMERIC ANTIGEN RECEPTOR-MODIFIED NATURAL KILLER CELLS
by: YANG CHIYUN
Published: (2018) -
Vγ9Vδ2 T cells expressing a BCMA-Specific chimeric antigen receptor inhibit multiple myeloma xenograft growth
by: Zhang, X, et al.
Published: (2022) -
EVALUATION OF NOVEL ANTIBODIES FOR CHIMERIC ANTIGEN RECEPTOR T CELL APPLICATIONS
by: LEONARD WEN YAN LEONG
Published: (2021) -
Fed-batch Medium Modification for Secreted Single Chain Variable Fragment Against HIV-1 p17 Protein Production Using Combined Two Factorial Experiments in Escherichia coli Bioreactor
by: Porntip Paopang
Published: (2017)